Mechanisms in CME

CME Module Index

Module 1: The Immune Response to Opportunistic Fungal Infections Module 1: The Immune Response to Opportunistic Fungal Infections

Fungi have emerged as a major cause of infection, particularly among immune compromised patients

CME Credits
0.75 AMA PRA
Category 1 Credits™

Module 2: Mechanisms of Action of Antifungal Agents Module 2: Mechanisms of Action of Antifungal Agents

The relatively unique structure of the fungal cell wall and cell membrane provide specific targets for many antifungal agents, not found in most other infectious agents or in human cells

CME Credits
0.5 AMA PRA
Category 1 Credits™

Module 3: Invasive Candida Infections Module 3: Invasive Candida Infections

Clinical manifestations of Candida infections include: candidemia, invasive candidiasis, disseminated candidiasis and candiduria

CME Credits
1.25 AMA PRA
Category 1 Credits™

Module 4: Invasive Aspergillosis Module 4: Invasive Aspergillosis

Aspergillosis is caused by the hyaline mold Aspergillus, which is responsible not only for invasive aspergillosis but also a variety of noninvasive or semi-invasive conditions

CME Credits
2.25 AMA PRA
Category 1 Credits™

Module 5: Zygomycosis Module 5: Zygomycosis

Zygomycosis is a term for a variety of fungal infections caused by members of the orders Mucorales and Entomophthorales

CME Credits
0.5 AMA PRA
Category 1 Credits™

Module 6: Treatment of Candidemia/Invasive Candidiasis and Candiduria Module 6: Treatment of Candidemia/Invasive Candidiasis and Candiduria

The Infectious Diseases Society of America Guidelines for the Treatment for Candidemia/Invasive Candidiasis state that for stable patients

CME Credits
1.50 AMA PRA
Category 1 Credits™

Module 7: Treatment of Invasive Aspergillosis Module 7: Treatment of Invasive Aspergillosis

Amphotericin B (AmB), the 3 lipid formulations of AmB (AmB colloidal dispersion, AmB lipid complex, and liposomal AmB), itraconazole, posaconazole, voriconazole

CME Credits
0 AMA PRA
Category 1 Credits™